株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国のバーチャル大腸内視鏡ソフトウェア市場

Virtual Colonoscopy Software Market Report | United States | 2019-2025 | MedCore

発行 iData Research Inc. 商品コード 379002
出版日 ページ情報 英文 70 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国のバーチャル大腸内視鏡ソフトウェア市場 Virtual Colonoscopy Software Market Report | United States | 2019-2025 | MedCore
出版日: 2019年02月01日 ページ情報: 英文 70 Pages
概要

当レポートでは、米国におけるバーチャル大腸内視鏡ソフトウェアの市場について分析し、全体的な市場規模の動向見通しや、主な市場促進・抑制要因、企業別の市場シェア、主要企業・製品のプロファイルなどを調査・推計すると共に、消化器疾患向け医療機器市場の全体的傾向 (疾患の概要、主な診断・治療機器、患者数、市場規模ほか) に関する情報も取りまとめてお届けいたします。

エグゼクティブ・サマリー

米国の消化器内視鏡装置市場の概要

競争分析

市場の傾向

市場の発展

処置件数

分析対象となる処置コード

分析対象市場

  • 主要分析の更新状況

過去のバージョン

調査手法

  • 調査範囲
  • IDATAの9段階の分析方法

疾患の概要

  • 人体の基本構造
  • 消化器疾患:治療・診断方法
    • 胃食道逆流症 (GERD)
    • バレット食道
    • 消火器がん
    • 胃腸出血
    • 胆道疾患
    • クローン病
    • 潰瘍
    • オギルヴィー症候群 (偽性腸閉塞)
  • 患者人口
    • 患者人口
      • 消化器疾患全体
      • 腹壁ヘルニア
      • 慢性便秘
      • 憩室性疾患
      • 処方箋
      • 胃食道逆流症 (GERD)
      • 胃腸感染症
      • 痔核
      • 炎症性腸疾患
      • 肝臓病
      • 膵臓炎
      • 消化性潰瘍
    • 消火器がん

製品評価

  • 製品ポートフォリオ
    • 仮想大腸内視鏡
      • イントロダクション
        • 製品マトリックス
  • 治験状況
    • 仮想大腸内視鏡
  • 製品パイプライン
    • Boston Scientific
    • Cook Inc.
    • オリンパス
    • Medtronic / Covidien
    • Avantis Medical Systems
    • Pentax Medical/ HOYA
    • 富士フイルム
    • US Endoscopy
    • CONMED Corporation
    • EndoChoice
    • Endogastric Solution
    • Mederi Therapeutics
    • C2 Therapeutics
    • Medigus
    • Merit Medical Systems, Inc.
    • Medivators, Inc.
    • Fujifilm Medical Systems USA, Inc.
    • Cook Medical
    • Vital Images, Inc.

仮想大腸内視鏡市場

  • 市場概要
  • 市場の分析と予測
  • 市場促進・抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 企業別の市場シェアの分析

略語一覧

図表

LIST OF CHARTS

  • Chart 4 1: Endoscopic Gastrointestinal Device Market by Segment, U.S., 2015 - 2025 2
  • Chart 4 2: Endoscopic Gastrointestinal Device Market Overview, U.S., 2018 & 2025 2
  • Chart 3 1: Virtual Colonoscopy Software Market, U.S., 2015 - 2025 53
  • Chart 3 2: Leading Competitors, Virtual Colonoscopy Software Market, U.S., 2018 60

LIST OF FIGURES

  • Figure 4 1: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (1 of 3) 3
  • Figure 4 2: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (2 of 3) 4
  • Figure 4 3: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (3 of 3) 4
  • Figure 4 4: Companies Researched in this Report 5
  • Figure 4 5: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (1 of 2) 6
  • Figure 4 6: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (2 of 2) 7
  • Figure 4 7: Recent Events in the Endoscopic Gastrointestinal Device Market, U.S., 2016 - 2018 8
  • Figure 4 8: Endoscopic Gastrointestinal Device Procedures Covered 9
  • Figure 4 9: Procedure Codes Investigated 10
  • Figure 4 10: Endoscopic Gastrointestinal Device Markets Covered (1 of 3) 11
  • Figure 4 11: Endoscopic Gastrointestinal Device Markets Covered (2 of 3) 12
  • Figure 4 12: Endoscopic Gastrointestinal Device Markets Covered (3 of 3) 13
  • Figure 4 13: Key Report Updates 14
  • Figure 4 14: Version History 15
  • Figure 2 1: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 - 2010 43
  • Figure 3 1: Virtual Colonoscopy Software Market, U.S., 2015 - 2025 52
  • Figure 3 2: Virtual Colonoscopy Workstation Penetration Rate, U.S., 2015 - 2025 (US$M) 52
  • Figure 3 3: Drivers and Limiters, Virtual Colonoscopy Software Market, U.S., 2018 56
  • Figure 3 4: Leading Competitors, Virtual Colonoscopy Software Market, U.S., 2018 59
目次
Product Code: iDATA_USGI19_MC_VC

Virtual colonoscopy is a procedure used for screening the large intestine for any polyps (abnormal growths), colorectal cancer and other diseases or defects. Unlike a regular colonoscopy, this procedure is non-invasive. Before the examination begins, a tube is inserted into the rectum to inflate the colon with air. This makes the colon larger and the surface area less convoluted, allowing for a clearer and more thorough examination. A laxative and a tagging agent are ingested by the patient prior to the procedure in order to reduce the amount of fecal matter in the colon and make the remainder easily distinguishable. Virtual colonoscopy does not require the use of a sedative, thus eliminating side-effect risks as well as allowing patients to return to their normal activities immediately following the procedure.

Adoption is expected to continue over the forecast period, but unit sales will continue exhibiting negative growth, due to the long lifespan of virtual colonoscopy software. One positive factor that might help counter unit erosion is the relative affordability of colonography against optical colonoscopy. Given the growing costs of colonoscopy screening in the United States, the market might turn its attention back to colonography.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES IV

LIST OF CHARTS V

EXECUTIVE SUMMARY 1

U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 6

MARKET DEVELOPMENTS 8

PROCEDURE NUMBERS 9

PROCEDURE CODES INVESTIGATED 10

MARKETS INCLUDED 11

KEY REPORT UPDATES 14

VERSION HISTORY 15

RESEARCH METHODOLOGY 16

    • Step 1: Project Initiation & Team Selection 16
    • Step 2: Prepare Data Systems and Perform Secondary Research 19
    • Step 3: Preparation for Interviews & Questionnaire Design 21
    • Step 4: Performing Primary Research 22
    • Step 5: Research Analysis: Establishing Baseline Estimates 24
    • Step 6: Market Forecast and Analysis 25
    • Step 7: Identify Strategic Opportunities 27
    • Step 8: Final Review and Market Release 28
    • Step 9: Customer Feedback and Market Monitoring 29

DISEASE OVERVIEW 30

  • 2.1 BASIC ANATOMY 30
  • 2.2 DISEASE TREATMENT & DIAGNOSTICS 32
    • 2.2.1 Gastroesophageal Reflux Disease 32
    • 2.2.2 Barrett's Esophagus 34
    • 2.2.3 GI Cancer 34
    • 2.2.4 GI bleeding 37
    • 2.2.5 Bile Duct Diseases 38
    • 2.2.6 Crohn's Disease 39
    • 2.2.7 Peptic Ulcer Disease 40
    • 2.2.8 Intestinal Pseudo-Obstruction and Ogilvie Syndrome 40
  • 2.3 PATIENT DEMOGRAPHICS 42
    • 2.3.1 GI Disorders 42
      • 2.3.1.1 General Statistics of GI Disorders for Different Years for the United States 43
      • 2.3.1.2 Abdominal Wall Hernia 44
      • 2.3.1.3 Chronic Constipation 45
      • 2.3.1.4 Diverticular Disease 45
      • 2.3.1.5 Prescriptions 45
      • 2.3.1.6 Gastroesophageal Reflux Disease 45
      • 2.3.1.7 Gastrointestinal Infections 46
      • 2.3.1.8 Hemorrhoids 46
      • 2.3.1.9 Inflammatory Bowel Disease 46
      • 2.3.1.10 Liver Disease 47
      • 2.3.1.11 Pancreatitis 47
      • 2.3.1.12 Peptic Ulcer Diseases 47
    • 2.3.2 GI Cancers 48

VIRTUAL COLONOSCOPY SOFTWARE MARKET 49

  • 3.1 INTRODUCTION 49
  • 3.2 MARKET ANALYSIS AND FORECAST 51
  • 3.3 DRIVERS AND LIMITERS 54
    • 3.3.1 Market Drivers 54
    • 3.3.2 Market Limiters 55
  • 3.4 COMPETITIVE MARKET SHARE ANALYSIS 57

ABBREVIATIONS 61

Back to Top